Inflammatory colitis associated with Teriflunomide

Esfahani, NZ; von Geldern, G; Romba, MC; Parikh, DA; Wundes, A

Esfahani, NZ (corresponding author), Univ Washington, Neurol, Seattle, WA 98195 USA.

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020; 46 ():

Abstract

Teriflunomide is an oral disease modifying therapy for relapsing-remitting multiple sclerosis (RRMS). Gastrointestinal (GI) side effects occurred in 1......

Full Text Link